Apogee Therapeutics, Inc. (APGE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 53.30 |
| Open | 52.89 |
| Bid | 53.65 x 200 |
| Ask | 53.84 x 100 |
| Day's range | 52.89 - 54.20 |
| 52-week range | 14.19 - 72.29 |
| Volume | |
| Avg. volume | 717,185 |
| Market cap | 3.03B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
With 54% institutional ownership, Apogee Therapeutics, Inc. (NASDAQ:APGE) is a favorite amongst the big guns
Key Insights Institutions' substantial holdings in Apogee Therapeutics implies that they have significant influence...
- Zacks
Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
Apogee (APGE) surges 95.6% in a month after reporting positive interim results from its phase I study for APG777 to treat AD. The company plans to initiate a phase II study for the same indication.
- Simply Wall St.
Insiders Of Apogee Therapeutics Reap Rewards After Their Investment Jumps Another US$74m
Last week, Apogee Therapeutics, Inc. ( NASDAQ:APGE ) insiders, who had purchased shares in the previous 12 months were...
© 2024 Yahoo. All rights reserved.